VIVODOTS™ nano-devices for detection, resection and management of pancreatic cancers

用于检测、切除和治疗胰腺癌的 VIVODOTS™ 纳米设备

• 批准号: 103357
• 金额: $ 105.77万
• 依托单位: NANOCO TECHNOLOGIES LIMITED
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2017
• 资助国家: 英国
• 起止时间: 2017 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=103357
• 关键词: VIVODOTS; nano; devices; detection; resection

A cancer imaging and therapeutic nano-device will be developed to enable better detection and treatment of lethal types of tumours, particularly pancreatic tumours. The design will be based on the use of biocompatible and fluorescent quantum dot nanoparticles (QDs) equipped with specific cancer targeting molecules. The proposed nano-device will enable more effective pre-, intra-, and post-operative management of pancreatic cancers, resulting in better surgical treatment, higher cure rates, and better quality of life for survivors. Later development should lead to the extrapolation of the same concept to other types of deadly malignancies.

将开发一种癌症成像和治疗纳米装置，以更好地检测和治疗致命类型的肿瘤，特别是胰腺肿瘤。该设计将基于使用配备有特定癌症靶向分子的生物相容性和荧光量子点纳米颗粒（QD）。拟议的纳米装置将使胰腺癌的术前、术中和术后管理更加有效，从而为幸存者提供更好的手术治疗、更高的治愈率和更好的生活质量。后来的发展应导致将同一概念外推到其他类型的致命恶性肿瘤。